48 related articles for article (PubMed ID: 11443151)
1. Cross-Cultural Disparities in Psychosocial Research with Individuals with Classical Congenital Adrenal Hyperplasia: A Scoping Review.
Traino KA; Basile NL; Chang HF; Fisher RS; Dattilo TM; Mullins LL; Ediati A; Wisniewski AB
Horm Res Paediatr; 2024; 97(2):99-105. PubMed ID: 37552959
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycaemia in adrenal insufficiency.
Lee SC; Baranowski ES; Sakremath R; Saraff V; Mohamed Z
Front Endocrinol (Lausanne); 2023; 14():1198519. PubMed ID: 38053731
[TBL] [Abstract][Full Text] [Related]
3. The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts.
de Miranda MC; Haddad LBP; Trindade E; Cassenote A; Hayashi GY; Damiani D; Costa FC; Madureira G; de Mendonca BB; Bachega TASS
Front Pediatr; 2021; 9():659492. PubMed ID: 34109139
[No Abstract] [Full Text] [Related]
4. Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Kinaan M; Hamidi O; Yau H; Courtney KD; Eraslan A; Simon K
J Endocr Soc; 2021 Jan; 5(1):bvaa158. PubMed ID: 33294761
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia.
Grosse SD; Van Vliet G
Int J Neonatal Screen; 2020 Oct; 6(4):. PubMed ID: 33239603
[TBL] [Abstract][Full Text] [Related]
6. Congenital Adrenal Hyperplasia with Salt Wasting Crisis: A Case Report.
Khanal D; Mandal D; Phuyal R; Adhikari U
JNMA J Nepal Med Assoc; 2020 Jan; 58(221):56-58. PubMed ID: 32335642
[TBL] [Abstract][Full Text] [Related]
7. Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence.
Miranda MC; Haddad LBP; Madureira G; Mendonca BB; Bachega TASS
J Endocr Soc; 2020 Feb; 4(2):bvz013. PubMed ID: 32047870
[TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia with salt-wasting crisis and arrhythmia: a case study.
Canlas JF; Ponmani C
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30700462
[TBL] [Abstract][Full Text] [Related]
9. Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.
Dörr HG; Wollmann HA; Hauffa BP; Woelfle J;
BMC Endocr Disord; 2018 Jun; 18(1):37. PubMed ID: 29884168
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of screening newborns for congenital adrenal hyperplasia.
Yoo BK; Grosse SD
Public Health Genomics; 2009; 12(2):67-72. PubMed ID: 19039250
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Riepe FG; Sippell WG
Rev Endocr Metab Disord; 2007 Dec; 8(4):349-63. PubMed ID: 17885806
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria.
Strnadová KA; Votava F; Lebl J; Mühl A; Item C; Bodamer OA; Torresani T; Bouska I; Waldhauser F; Sperl W
Eur J Pediatr; 2007 Jan; 166(1):1-4. PubMed ID: 17024350
[TBL] [Abstract][Full Text] [Related]
14. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
Török D; Eckhardt G; Sólyom J
Eur J Pediatr; 2003 Dec; 162(12):844-9. PubMed ID: 14648216
[TBL] [Abstract][Full Text] [Related]
15. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries.
Kovács J; Votava F; Heinze G; Sólyom J; Lebl J; Pribilincová Z; Frisch H; Battelino T; Waldhauser F;
J Clin Endocrinol Metab; 2001 Jul; 86(7):2958-64. PubMed ID: 11443151
[TBL] [Abstract][Full Text] [Related]
16. Congenital adrenal hyperplasia: lessons from a multinational study.
Frisch H; Waldhauser F; Lebl J; Solyom J; Hargitai G; Kovacs J; Pribilincova Z; Krzisnik C; Battelino T;
Horm Res; 2002; 57 Suppl 2():95-101. PubMed ID: 12065936
[TBL] [Abstract][Full Text] [Related]
17. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
[TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
[TBL] [Abstract][Full Text] [Related]
19. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?
Grosse SD; Van Vliet G
Horm Res; 2007; 67(6):284-91. PubMed ID: 17199092
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
